Validating The Efficacy Of A Compound With Spatial Imaging

By Corinne Ramos, Ph.D. Director, Research and Development, ImaBiotech

In the current drug development environment, sponsors need to affectively generate quality efficacy data to assess drug candidacy. In precision medicine, and in oncology specifically, this process requires an understanding of the potential disease heterogeneity across and within patients and the changes that occur upon drug administration within the tumor microenvironment.

Spatial analysis tools offer a molecular look into the interactions between cells within the context of the disease and provide powerful visualizations into the changes that occur upon drug administration. Discover how target and efficacy validation can translate into substantial savings and market advantages for sponsors as a result of shortened development and approval timelines.